spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR001461 Peptidase A1

Protein matchesHelp
UniProtKB
Matches:
3378 proteins
AccessionHelp IPR001461 Peptidase_A1
TypeHelp Family
SignaturesHelp
InterPro RelationshipsHelp
Children IPR009119 Peptidase A1, beta-site APP cleaving enzyme, BACE
IPR016952 Small heat shock protein, predicted, plant
Contains IPR001969 Peptidase aspartic, active site
IPR007856 Saposin-like type B, 1
IPR008138 Saposin-like type B, 2
IPR009007 Peptidase aspartic, catalytic
GO Term annotationHelp
Process GO:0006508 proteolysis
Function GO:0004190 aspartic-type endopeptidase activity
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:

  • Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins.
  • Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule.

In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding.

Aspartic endopeptidases EC:3.4.23. of vertebrate, fungal and retroviral origin have been characterised [1]. More recently, aspartic endopeptidases associated with the processing of bacterial type 4 prepilin [2] and archaean preflagellin have been described [3, 4].

Structurally, aspartic endopeptidases are bilobal enzymes, each lobe contributing a catalytic Asp residue, with an extended active site cleft localised between the two lobes of the molecule. One lobe has probably evolved from the other through a gene duplication event in the distant past. In modern-day enzymes, although the three-dimensional structures are very similar, the amino acid sequences are more divergent, except for the catalytic site motif, which is very conserved. The presence and position of disulphide bridges are other conserved features of aspartic peptidases. All or most aspartate peptidases are endopeptidases. These enzymes have been assigned into clans (proteins which are evolutionary related), and further sub-divided into families, largely on the basis of their tertiary structure.

This group of aspartic peptidases belong to MEROPS peptidase family A1 (pepsin family, clan AA). The type example is pepsin A from Homo sapiens (Human) .

More than 70 aspartic peptidases, from all from eukaryotic organisms, have been identified. These include pepsins, cathepsins, and renins. The enzymes are synthesised with signal peptides, and the proenzymes are secreted or passed into the lysosomal/endosomal system, where acidification leads to autocatalytic activation.

Most members of the pepsin family specifically cleave bonds in peptides that are at least six residues in length, with hydrophobic residues in both the P1 and P1' positions [5]. Crystallography has shown the active site to form a groove across the junction of the two lobes, with an extended loop projecting over the cleft to form an 11-residue flap, which encloses substrates and inhibitors within the active site [5]. Specificity is determined by several hydrophobic residues surrounding the catalytic aspartates, and by three residues in the flap. Cysteine residues are well conserved within the pepsin family, pepsin itself containing three disulphide loops. The first loop is found in all but the fungal enzymes, and is usually around five residues in length, but is longer in barrierpepsin and candidapepsin; the second loop is also small and found only in the animal enzymes; and the third loop is the largest, found in all members of the family, except for the cysteine-free polyporopepsin. The loops are spread unequally throughout the two lobes, suggesting that they formed after the initial gene duplication and fusion event [5].

This family does not include the retroviral nor retrotransposon aspartic proteases which are much smaller and appear to be homologous to the single domain aspartic proteases.

Structural linksHelp
PDB - click here
SCOP: a.64.1.2 , b.50.1.2
CATH: 2.40.70.10
Database linksHelp
Enzyme: EC:3.4.23
PANDIT: PF00026
Blocks: IPB001461
MEROPS: A1
Pfam Clan: CL0129.10

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR001461 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O01530 Aspartic protease 6

P00790 Pepsin A

P00796 Renin-2

P07267 Saccharopepsin

Q9LX20 Aspartic proteinase-like protein 1

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR012848 Propeptide, peptidase A1
IPR001461 Peptidase A1
IPR001969 Peptidase aspartic, active site
IPR009007 Peptidase aspartic, catalytic
SWISS-MODEL
PDB Chain
ModBase
SCOP Domain
CATH Domain

PublicationsHelp
1. Szecsi PB.
The aspartic proteases.
Scand. J. Clin. Lab. Invest. Suppl. 210 5-22 1992 [PubMed: 1455179]
2. LaPointe CF, Taylor RK.
The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases.
J. Biol. Chem. 275 1502-10 2000 [PubMed: 10625704]
http://dx.doi.org/10.1074/jbc.275.2.1502
3. Ng SY, Chaban B, Jarrell KF.
Archaeal flagella, bacterial flagella and type IV pili: a comparison of genes and posttranslational modifications.
J. Mol. Microbiol. Biotechnol. 11 167-91 2006 [PubMed: 16983194]
http://dx.doi.org/10.1159/000094053
4. Bardy SL, Jarrell KF.
Cleavage of preflagellins by an aspartic acid signal peptidase is essential for flagellation in the archaeon Methanococcus voltae.
Mol. Microbiol. 50 1339-47 2003 [PubMed: 14622420]
http://dx.doi.org/10.1046/j.1365-2958.2003.03758.x
5. Rawlings ND, Barrett AJ.
Families of aspartic peptidases, and those of unknown catalytic mechanism.
Meth. Enzymol. 248 105-20 1995 [PubMed: 7674916]
http://dx.doi.org/10.1016/0076-6879(95)48009-9

Additional ReadingHelp
Beswick P, Charrier N, Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Gleave R, Hawkins J, Hussain I, Johnson CN, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Skidmore J, Soleil V, Smith KJ, Stanway S, Stemp G, Stuart A, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G.
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells.
Bioorg. Med. Chem. Lett. 18 2008 1022-6 [PubMed: 18171615]
http://dx.doi.org/10.1016/j.bmcl.2007.12.020
Sielecki AR, Fujinaga M, Read RJ, James MN.
Refined structure of porcine pepsinogen at 1.8 A resolution.
J. Mol. Biol. 219 1991 671-92 [PubMed: 2056534]
http://dx.doi.org/10.1016/0022-2836(91)90664-R
Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G.
BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.
Bioorg. Med. Chem. Lett. 18 2008 1017-21 [PubMed: 18166458]
http://dx.doi.org/10.1016/j.bmcl.2007.12.019
Miller M, Jaskolski M, Rao JK, Leis J, Wlodawer A.
Crystal structure of a retroviral protease proves relationship to aspartic protease family.
Nature 337 1989 576-9 [PubMed: 2536902]
http://dx.doi.org/10.1038/337576a0
Iserloh U, Wu Y, Cumming JN, Pan J, Wang LY, Stamford AW, Kennedy ME, Kuvelkar R, Chen X, Parker EM, Strickland C, Voigt J.
Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
Bioorg. Med. Chem. Lett. 18 2008 414-7 [PubMed: 18023580]
http://dx.doi.org/10.1016/j.bmcl.2007.10.116
Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G.
BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs).
Bioorg. Med. Chem. Lett. 18 2008 1011-6 [PubMed: 18171614]
http://dx.doi.org/10.1016/j.bmcl.2007.12.017
Iserloh U, Pan J, Stamford AW, Kennedy ME, Zhang Q, Zhang L, Parker EM, McHugh NA, Favreau L, Strickland C, Voigt J.
Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor.
Bioorg. Med. Chem. Lett. 18 2008 418-22 [PubMed: 17980584]
http://dx.doi.org/10.1016/j.bmcl.2007.10.116
spacer
spacer
InterPro 23.1